COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for release of actual court opinion or docket update; current filing appears to be a system-generated placeholder with no legal substance
Final — all horizons settled through T+60d ⚠ clustered
BIIB ▲ +6.77% at T+60d
NEUTRAL call ✓ call won +6.77% · α vs SPY -9.25% · entry $186.93 → $199.59
T+1d
-2.36%
call -2.36% · α -5.25%
$182.52
settled 6mo ago
T+5d
-6.05%
call -6.05% · α -10.35%
$175.61
settled 6mo ago
T+20d
-2.03%
call -2.03% · α -14.63%
$183.13
settled 5mo ago
T+60d
+6.77%
call +6.77% · α -9.25%
$199.59
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the Northern District of Illinois
Court Level
District
Case Type
contract
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Key Facts
- Case: Walgreen Co. et al v. Biogen, Inc. (1:25-cv-11680), filed in the United States District Court for the Northern District of Illinois
- Filed on 2026-03-30, status is unknown
- No substantive opinion or ruling text available — only a procedural placeholder or login redirect was provided
Financial Impact
No financial impact can be assessed due to lack of content
Risk Factors
- Potential for material ruling once full opinion is released
- Uncertainty due to lack of accessible ruling details
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
47% bullish (43 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-3qxgjdmg-BIIB |
25 reports for BIIB
92% Hit rate best @ T+60▲ +11.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 28d ago | Press Release | $220.83 $217.36 | ▼ −1.57% | ▼ −0.36% | $219.88 (−0.43%) |
Sep 3, 2026 29d ago | Press Release | $224.51 $217.15 | ▼ −3.28% | ▼ −2.13% | $219.88 (−2.06%) |
Aug 6, 2026 8w ago | Press Release | $207.94 $209.83 | ▲ +0.91% | ▲ +0.51% | $219.88 (+5.74%) |
Jul 14, 2026 11w ago | Press Release | $191.95 $199.95 | ▲ +4.17% | ▲ +5.46% | $219.88 (+14.55%) |
Jul 13, 2026 11w ago | Press Release | $191.95 $199.95 | ▲ +4.17% | ▲ +5.46% | $219.88 (+14.55%) |
Jul 13, 2026 11w ago | ANALYST-UPGRADE | — | awaiting T+5 | — | — |
Jun 17, 2026 15w ago | Press Release | $196.58 $201.96 | ▲ +2.74% | ▲ +4.40% | $219.88 (+11.85%) |
Jun 8, 2026 16w ago | ANALYST-UPGRADE | $192.62 $198.64 | ▲ +3.13% | ▲ +1.01% | $219.88 (+14.15%) |
Jun 4, 2026 17w ago | Press Release | $195.82 $199.96 | ▲ +2.12% | ▲ +4.67% | $219.88 (+12.29%) |
Jun 1, 2026 17w ago | Press Release | $192.22 $195.34 | ▲ +1.63% | ▲ +4.38% | $219.88 (+14.39%) |
Showing 10 of 25
US Market Status
Market Closed — Opens Mon (65h 5m)
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access